daniel mogollon

Daniel mogollon

The system can't perform the operation now. Try again later. Citations per year. Duplicate citations.

Atovaquone-proguanil AP is used as treatment for uncomplicated malaria, and as a chemoprophylactic agent against Plasmodium falciparum. Imported malaria remains one of the top causes of fever in Canadian returning travelers. Twelve sequential whole-blood samples before and after AP treatment failure were obtained from a patient diagnosed with P. Ultradeep sequencing was performed on the cytb, dhfr, and dhps markers of treatment resistance before and during the episode of recrudescence. Haplotyping profiles were generated using three different approaches: mspD7 agarose and capillary electrophoresis, and cpmp using amplicon deep sequencing ADS. A complexity of infection COI analysis was conducted. De novo cytb YC mutants strains were observed during an episode of recrudescence 17 days and 16 h after the initial malaria diagnosis and AP treatment initiation.

Daniel mogollon

.

Verified email at ucalgary. Antimicrobial Agents and Chemotherapy 67 6e ,

.

Introduction : Historically, the global community has focused on the control of symptomatic malaria. However, interest in asymptomatic malaria has been growing, particularly in the context of malaria elimination. Areas covered : We undertook a comprehensive PubMed literature review on asymptomatic malaria as it relates to detection and elimination with emphasis between and Diagnostic tools with a low limit of detection LOD have allowed us to develop a more detailed understanding of asymptomatic malaria and its impact. These highly sensitive diagnostics have demonstrated that the prevalence of asymptomatic malaria is greater than previously thought. In addition, it is now possible to detect the malaria reservoir in the community, something that was previously not feasible. Asymptomatic malaria has previously not been treated, but research has begun to examine whether treating individuals with asymptomatic malaria may lead to health benefits.

Daniel mogollon

Listen in each week for previews, analysis, and recruiting info, along with interviews. The Michigan Insider's Brice Marich joins host Danny Mogo to talk about Michigan's big early signing day effort and give his expert opinion on the Wolverines recruiting class. We also discuss what's different about the Wolverines compared to Coach Harbaugh's previous teams, the surprisingly seamless coaching changes this season, and the potential of this being a new beginning for the program. Host Danny Mogo ends the pod with a quick look at the latest in recruiting news with Early Signing Day a week away.

Lice killing machine

Journal of Clinical Microbiology, e , Their combined citations are counted only for the first article. Faisal Khan Cranfield University Verified email at cranfield. Our findings highlight the value of ultra-deep sequencing methods in the understanding of P. Email address for updates. The following articles are merged in Scholar. Clinical Applications of Nucleic Acid Amplification , , Citations per year. Title Sort Sort by citations Sort by year Sort by title. View all. Citations per year. Get my own profile Cited by All Since Citations h-index 5 5 iindex 4 4. View all. New articles related to this author's research.

.

Title Sort Sort by citations Sort by year Sort by title. Email address for updates. This "Cited by" count includes citations to the following articles in Scholar. Title Sort Sort by citations Sort by year Sort by title. Journal of Clinical Virology , , Verified email at ucalgary. Expert review of anti-infective therapy 17 12 , , Merged citations. No YC mutant reads were observed in any of the samples prior to the recrudescence. New articles related to this author's research. Journal of Clinical Microbiology, e ,

3 thoughts on “Daniel mogollon

  1. It is a pity, that now I can not express - there is no free time. I will return - I will necessarily express the opinion on this question.

  2. Completely I share your opinion. It seems to me it is excellent idea. Completely with you I will agree.

Leave a Reply

Your email address will not be published. Required fields are marked *